New startup ideas · Health and bio · Healthcare and bio
startup idea
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
- Infrastructure and APIs
- Enterprise
- $100B+ market
- Creates a new category
- US first
5/5
venture judge
36
similar startups, last 2 years (135 all-time)
97%
of 4 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Test it before you build it
$1,000 · 4 weeks · 15 prospects
For $1,000 and 4 weeks, prove founders of AI-native clinics will pay per record for consent-verified retrieval - with paid reservations in hand - before ChartRail holds any qualification.
Riskiest assumption · Founders of AI-native clinics treat consented full-record retrieval as a launch blocker they will commit money to now, per record, to a third party that does not yet hold its exchange qualification, rather than stitching together Hubble and direct health-system connections themselves.
1Focus group: who and where
Founder or founding clinical-ops lead at a seed-stage AI-native care startup (2-15 people, YC S26/X26 vintage like Standard Medical, Clara or Radley) that must show a patient's longitudinal record at the first visit, is weeks from launching, and has no compliance hire.
where to find 15 · The Health Tech Nerds Slack community, where AI-clinic founders and their first hires already discuss records access; the YC Startup Directory filtered to S26 and X26 healthcare companies, which lists the ten newest AI clinics by name with founder contacts; direct outreach on X, where these founders post launch threads and reply to builders; plus Out-Of-Pocket's community for warm paths to the same people.
2Sell first, build later
A launch-partner package sold before any qualification exists: guaranteed slot in ChartRail's first integration cohort, one REST endpoint returning a patient's complete record with verifiable consent, white-glove integration within 30 days of network go-live targeted for mid-2027, and 12 months at a locked per-record price.
the ask · $1.00 per record retrieved with a $500 monthly minimum once live; $1,000 refundable reservation today
a real yes · A real yes is a paid $1,000 reservation with a signed launch-partner agreement; a signed LOI with a dated integration slot is a weak yes to log separately; compliments, 'we would definitely use this', intros to their EHR contacts, and unpaid pilot interest count as nothing.
3Small experiments
The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.
1. Founder pain and price calls
$100 · 10 days
Build a one-page offer in Notion: a mock REST endpoint spec, $1.00 per record retrieved, and launch-partner terms. DM or email 15 AI-clinic founders through Health Tech Nerds and the YC directory and run 20-minute calls: first ask exactly how they plan to get a new patient's records on day one and what it costs them today, then pitch the offer at the end. The founder runs every call personally.
keep going if · 8 of 15 founders say records retrieval blocks or delays patient onboarding today, and 5 of 15 ask to see the launch-partner terms
2. Reservation close
$150 · 14 days
Send the one-page launch-partner agreement by e-signature to every founder who asked for terms, then invoice a $1,000 refundable reservation payable by ACH. Follow up twice within a week; log every stated reason for not paying verbatim.
keep going if · 3 of 15 pitched founders sign and pay the $1,000 reservation
3. Permitted-purpose counsel check
$750 · 10 days
Book one-hour paid consults with two health-data attorneys who have worked on TEFCA participation or clearinghouse registration, and put the exact question to each: can a third party retrieve records on behalf of AI-native clinics under a permitted purpose (treatment or individual access services) without that standing being revocable overnight. Get the answer in writing, even as an email summary.
keep going if · 2 of 2 attorneys confirm a workable permitted-purpose path for AI-clinic customers; a written no from either is an immediate kill
4Collect a deposit up front
Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.
$1,000
per prospect, refundable
how · A refundable launch-partner reservation, invoiced directly and paid by ACH - seed-stage founders can move $1,000 the same week without any procurement process, and paying before the rail exists is precisely the belief being tested; the founder signs a one-page launch-partner agreement locking the price and the slot. set up: Stripe Invoicing ↗
what it reserves · One of 5 launch-partner slots, $1.00 per record locked for the first 12 months, and first-cohort white-glove integration.
refund · Refundable in full any time before integration begins, and refunded automatically if ChartRail's exchange qualification is not granted by June 2027.
target · 3 paid reservations from 15 founder conversations within 30 days
before taking money · Do not move, cache or display real patient data anywhere - even in demos - until HIPAA and TEFCA counsel confirm the permitted-purpose standing and BAAs are in place; during the test, sell reservations, never records.
Go: build it if
3 of 15 founders pay the $1,000 reservation, at least 8 of 15 name records retrieval as a launch blocker, and both attorneys confirm a permitted-purpose path - start the qualification process and build the endpoint.
Kill: stop if
0 reservations from 15 pitched founders, fewer than 5 of 15 name records as a launch blocker, or either attorney puts in writing that AI-clinic retrieval has no durable permitted-purpose path.
5 Scripts to run itoutreach message, landing copy, deposit terms · click to open
outreach message
You're launching an AI clinic, which means before your first patient visit you need their complete history - and today that means Hubble, faxes, or begging health systems one by one. I'm building ChartRail: one REST endpoint that returns the full record with verifiable consent, backed by our own exchange qualification, at $1 per record. I'm signing 5 launch partners who lock that price and shape the API before we go live. Open to a 20-minute call this week?
landing page
Every patient's complete medical record, one API call, consent verified. $1.00 per record - launch partners lock that price for 12 months with a $1,000 refundable reservation. Reserve a launch-partner slot.
deposit terms
Your $1,000 reservation holds one of 5 launch-partner slots and locks $1.00 per record for your first 12 months, with white-glove integration in our first cohort, targeted for mid-2027. It is fully refundable any time before your integration starts, no questions asked. If our exchange qualification is not granted by June 2027, we refund automatically.
Would you run this test?
One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.
Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
70
Idea Score, 0-100 · raw 43.5 x 1.61
Crowded
competition: more crowded than 95% of ideas · headwind x0.53
+4.8
government priorities, secondary (171 matching grants)
Trend
73
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)49
- Rounds announced 2025+ in the sector69
- Sector direction (live batch)100
- 2026 trend analyst75
Demand
68
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain75
100x potential
80
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge100
- Market size axis100
- Moat axis80
- Neighbours still alive74
- Technologist judge25
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were consented, medical-records, rail, clinic, ai-native, care, pull, patient.
The idea in full
- What
- An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse. Customers integrate one REST endpoint instead of negotiating with hundreds of health systems; ChartRail's regulatory standing does the work, not novel ML. Pricing is per record retrieved, so revenue starts with the first customer's first patient.
- Why now
- The YC S26 and X26 batches are stacked with AI-native care delivery - Standard Medical's AI primary care clinic, Clara's AI primary care doctor, Radley's AI-native radiology practice - and Hubble's pitch is literally 'Retrieve records other APIs can't', which shows the rail is missing and buyers already feel it.
- Wedge: first customer and entry point
- Founder-led sales to the ten newest AI-clinic startups, who all need longitudinal records before their first patient visit and have no compliance team to build access themselves.
- Path to 100x
- US healthcare data exchange and the administration around it is a $100B+ spend, and a new category - the consent-and-records rail for autonomous care - gets defined by whoever the first hundred AI clinics standardize on. The qualification is slow and political to obtain, so incumbency in the license compounds while integration switching costs lock customers in.
- Ceiling
- EHR vendors open equivalent APIs natively and the rail becomes a feature of the systems it was routing around.
- Closest real companies, as the generator saw them
- Hubble retrieves records but sells retrieval as a capability; ChartRail's difference is making regulatory qualification itself the product, so access rights and consent standing, not scraping skill, are what customers buy. Standard Medical and Clara are buyers, not rivals.
- Main risk
- The exchange frameworks tighten rules against third-party AI use cases and ChartRail's permitted-purpose standing evaporates overnight.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
5/5
Capital-light, revenue from the first record, and a slow political qualification that compounds while the first hundred AI clinics standardize on it.
Bootstrapper
3/5
Per-record revenue from day one on software margins, but the exchange-framework qualification is slow and political and can be revoked.
Operator
4/5
AI clinics need longitudinal records before their first visit, pay per record from day one, and have no compliance team to build access themselves.
Technologist
2/5
The card states regulatory standing, not novel ML, is the product, and EHR vendors shipping native APIs erases it.
Risk
2/5
The entire product is one permitted-purpose standing in a national exchange framework the card admits could evaporate overnight, sold to ten new AI clinics.
trends
4/5
Its buyers - AI-native clinics like Standard Medical, Clara, Radley - only exist since the 2025-2026 batches, and slow regulatory qualification rewards moving now.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (consented, medical-records, rail, clinic, ai-native, care, pull, patient): 135 all-time, 36 from the last two years. Same matching as Idea Check.
AI-native patient engagement
The operations stack for biologic infusion clinics
Logistics infrastructure to modernize healthcare operations
AI-native operating system for behavioral health clinics.
Software to launch and integrate genetics into clinical care
Autonomous medical care
Osteoboost is the first and only FDA-cleared, drug-free prescription treatment for low bone density and a platform for a comprehensive solution to osteoporosis.
Smart Sensors For Surgical Site Infection Risk Detection
NOVAJoint is a regenerative implant company focused on restoring native joint function through implanting biologic living joint replacements.
Pioneering the Future of Tendon and Ligament Repair
Remote patient monitoring for musculoskeletal health
Levisonics is developing a drop-of-blood, point-of-care coagulation analyzer that delivers in a single test the comprehensive clotting insights that today require multiple separate lab and point-of-care tests.
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1595
startup-relevant grants in Healthcare and bio
$854M
awarded in the sector, tracked
118
opportunities open now in the sector
NIH / NIA · SBIR phase II · $506K · posted 2025-09-22
- Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorderawardhigh relevance
NIH / NIDA · SBIR phase I · $307K · posted 2025-09-01
- Early Alerts, Safer Births: A Wearable Device for Real-time Maternal Hemorrhage Monitoringawardhigh relevance
NIH / NCCDPHP · SBIR phase II · $1M · posted 2026-09-30
NIH / NIA · SBIR phase II · $1M · posted 2026-09-23
- PulmoZ: A wearable bioimpedance-sensing patch for remote pulmonary function assessment in ALSawardhigh relevance
NIH / NINDS · STTR phase I · $472K · posted 2026-09-23
NIH / NIA · SBIR phase II · $1M · posted 2026-09-22
NIH / NIA · SBIR phase I · $500K · posted 2026-09-22
- Prevention of Amputation with Rapid Healing of Diabetic Ulcers Using Autologous Microsized Fat Tissueawardhigh relevance
NIH / NIDDK · SBIR phase I · $313K · posted 2026-09-22
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 135 → 121 → 224 → 173 → 127 new companies 2022 → 2026 · 91% aliveYC F26 live: 2 in this cluster, 2% of the batch (was 6% in S26)Since February, of 442 YC companies here: 6 acquired, 6 shut down, 45 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Enterprise
- Business model
- Infrastructure and APIs
- Path to 100x
- Creates a new category
- Market size
- $100B+ market
- Capital intensity
- Capital-light (software margins)
- Speed to revenue
- Revenue within a year
- Technical depth
- Integrations, no-code
- Go-to-market
- Founder-led sales
- Moat
- License or regulatory moat
- Geography
- US first
- Regulation
- Some regulation
- Vibe
- Boring business
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
Claimsmith
The agent platform where healthcare's back office gets rebuilt by everyone but us.
Claimsmith is a no-code platform where hospitals, billing companies, and health IT vendors build and run AI agents for administrative work: eligibility checks, prior authorization, claims appeals, and records chasing.
Fictional company written 2026-08-26 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.